Nanoscope Therapeutics Press Releases
-
Nanoscope Publishes Breakthrough Showing MCO-010 Treatment Arrests Neurodegeneration
October 21, 2024 by Nanoscope Therapeutics
-
Nanoscope Announces Presentations at the American Academy of Ophthalmology Annual Meeting 2024
October 15, 2024 by Nanoscope Therapeutics
-
Nanoscope Announces Plans to Submit BLA for MCO-010 to Treat Retinitis Pigmentosa
October 10, 2024 by Nanoscope Therapeutics
-
Nanoscope Therapeutics Licenses Optogenetic CatCh Technology
September 30, 2024 by Nanoscope Therapeutics
Nanoscope Therapeutics In the News
- Max-Planck-Gesellschft: Nanoscope Therapeutics licenses optogenetic technology
- HCP Live: Nanoscope Reports Positive End-of-Phase 2 Meeting for MCO-010 Gene Therapy
- Retina Specialist: ARVO 2024 Highlights – Optogenetic therapy for retinitis pigmentosa yields BCVA improvement at one year
- Ocular Surgery News: VIDEO: MCO-010 for retinitis pigmentosa improves vision in phase 2b/3 study
- Modern Retina: ASRS 2024: RESTORE trial 100-week results presented by Dr. Michael Singer